Abstract: The present disclosure relates to a pharmaceutically stable soft capsule formulation containing two or more different compositions, wherein each single ingredient can be formulated as a composite formulation, and a formulation with improved stability can be provided by minimizing a reaction between two or more different compositions.
Type:
Application
Filed:
December 20, 2021
Publication date:
September 5, 2024
Applicant:
COSMAXPHARMA CO.,LTD.
Inventors:
Myounghoon PARK, Sohee YOON, Subong HONG, Jihye CHOI